Disposition of 14C-LY2886721 Following Oral Administration in Healthy Human Subjects
A Study of Two Dosage Forms of LY2886721 in Healthy Participants
A Safety Study of LY2886721 Multiple Doses in Healthy Subjects
A Study of LY2886721 in Healthy Participants
A Safety Study of LY2886721 Single Doses in Healthy Subjects
A Study of LY2886721 in Healthy Participants and Participants Diagnosed With Alzheimer's Disease
Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease
† Study has passed its completion date and status has not been verified in more than two years.